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In this issue ofCell StemCell, Chung et al. (2008) remove a single blastomere to generate a human embryonic
stem cell (hESC) line without prejudicing the development of the biopsied embryo. Their method stimulates
new ideas about hESC formation, but ethicopolitical concerns remain.Previous experiments on mouse embryos
showed that embryonic stem (ES) cell
lines can be obtained from biopsied indi-
vidual blastomeres and that the remain-
ing embryo can produce a live offspring
(Chung et al., 2006; Teramura et al.,
2007). Applying a similar approach to hu-
man embryos, Klimanskaya et al. (2006)
showed that isolated human blastomeres
could indeed form hESCs at low fre-
quency. However, their methodologies
(embryo dispersal and destruction) and
culture conditions (using carrier hESCs)
raised concerns and precluded develop-
ment of the biopsied embryo. Now the
same laboratory has used more rigorous
culture methods to demonstrate that a
single blastomere isolated from an eight
to ten cell embryo can form an hESC line
and that the biopsied human embryo can
develop to a blastocyst. This outcome
provides the best demonstration of biop-
sied embryo normality short of uterine
transfer. Given that the biopsy procedure
utilized is similar to that employed during
preimplantation genetic diagnosis (PIGD),
the biopsied embryos are predicted to be
functional. This latest report has gener-
ated political and ethical comment but
little biological interest. This is a pity, be-
cause within it lie pointers to the molecular
mechanisms underlying both blastocyst
formation and ESC generation.
Early attempts to derive ESCs from sin-
gle blastomeres isolated from morulae
failed, the usual outcome being a small
cluster of trophoblast cells. This outcome
was explained by the distinctive proper-
ties of early blastomeres. During embryo-
genesis, the six cleavage divisions lead-
ing from a fertilized egg to a blastocyst
appear to be programmed such that key
developmental changes occur in particu-
lar developmental cell cycles. In particu-lar, during the eight cell stage (the point
at which the developing embryos were
biopsied in this study), blastomeres trans-
form their phenotype from nonpolar to
polarized. This polarization is followed
by two rounds of division in which cells
are allocated to different positions and
phenotypes: differentiative divisions gen-
erate a nonpolar inner and a polar outer
cell, while conservative divisions generate
two polar outer cells (Johnson and
McConnell, 2004). Thus, the ratio of inner
to outer cells depends critically on the
relative numbers of each division type,
which are affected by cell shape and cell
interactions (Johnson and McConnell,
2004). When starting with an isolated
eight cell blastomere, most divisions
seem to be conservative and too few inner
cells form. It is these cells that are the pre-
cursors of the ESCs. So, in order to max-
imize the chance of a single eight cell
blastomere yielding an ESC line, all or
most cells derived from it must develop
along the ‘‘inside, nonpolar’’ route. This
might be achieved by suppressing (or re-
versing) polarization so that all cells be-
come epiblast-like or, should polarization
occur, by maximizing the number of dif-
ferentiative divisions such that the ratio
of nonpolar epiblast to polar trophoblast
cells is maximized.
In previous publications on the genera-
tion of ES cells from mouse single blasto-
meres, it has not been possible to under-
stand which, if either, of these routes to
epiblast was operating, nor how. Chung
et al. (2008), however, suggest not only
that the critical molecular additive is lam-
inin but also that it acts by disrupting
polarization—as evidenced by disordered
tight junctions and the lack of polarized
microvilli. This finding is exciting not only
with respect to ESC derivation but alsoCell Stem Cfor the hints it provides for our basic
understanding of early developmental
mechanisms. Of note, laminin is the first
extracellular protein to be synthesized in
the mouse embryo, being present from
around the eight cell stage (Cooper and
MacQueen, 1983). Moreover, laminin is
known to influence the distribution of cad-
herins (Klaffky et al., 2006), and E-cadherin
redistribution to the inner surface of blasto-
meres is a key early event in polarization
(Johnson and McConnell, 2004). Might, in
the normal embryo, the deposition of
laminin between blastomeres stimulate,
through its asymmetric distribution, the re-
distribution of E-cadherin and so initiate
the polarization of the blastomeres? And,
by surrounding an isolated blastomere
with laminin, might this asymmetric posi-
tional signaling be lost and so polarization
absent? These are the exciting and funda-
mental questions raised almost serendipi-
tously by this study. We now need to
know more about the time course and na-
ture (prevention or reversal?)of polaritydis-
ruption. In addition, laminin has at least 15
isoforms, with distinct expression and dis-
tribution patterns, including differences be-
tween ICM and trophoblast (Klaffky et al.,
2006). The laminin used in this study is
a mixture of isotypes and proteolytic lami-
nin fragments (Wondimu et al., 2006), and
so a more accurate identification of the
active component(s) is needed.
But what about the clinical impact of the
paper and its ethicopolitical implications?
One must ask: why is this work being
done? It is difficult to see any direct clinical
value. One hopes it is not a prelude to
clinics promoting IVF for fertile couples
with the prospect of a cryobankable
hESC line fully compatible with their child.
Such an offer would be unethical given
the complex nature and appreciable failureell 2, February 2008 ª2008 Elsevier Inc. 103
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The treatment would require IVF, blasto-
mere biopsy, temporary cryopreservation
of biopised embryos, derivation of ESC
lines and their cryopreservation, and then
selective thawing and uterine transfer of
embryos with genetically matching hESC
lines. There is currently no demonstrated
advantage over cord blood banking—
a much less invasive and easier procedure.
The political motivation is also problem-
atic. In the United States, federal funding
of hESC derivation is prohibited unless
‘‘no harm’’ is done to the embryo. It is un-
clear whether this new technique will sat-
isfy the ethical criterion of no harm, and
statements from the administration that
followed online publication of the article
were equivocal at best. Paradoxically, it
is the same no harm stimulus that may
scupper federal approval. Thus, the
same political motivation is also driving
the high investment in efforts to derive in-
duced pluripotent stem cells (iPSCs) from
skin cells. This technology is fraught with
dangers, including oncogenesis, but its
promotion as a potential alternative to the
use of human embryos may provide a po-
tent disincentive to approve use of this
new technique.A New Role for an
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NFAT proteins are calcium-regulate
activation of many vertebrate tissue
the calcineurin-NFAT-CDK4 pathwa
‘‘Knowledge of the hair cycles and
their control will undoubtedly give
needed insight into many compli-
cated growth processes of other
body structures which are not at
present well understood.’’
—Earl O. Butcher (Butcher, 1934)
104 Cell Stem Cell 2, February 2008 ª2008 EPerhaps it is time that consumer socie-
ties faced the fact that IVF, PIGD, and
associated reproductive technologies
(ARTs) all involve research on and de-
struction of human embryos. Attempts
like those above, and others involving
genetically disabling an embryo (Meissner
and Jaenisch, 2006) or attempting rescue
of living blastomeres from otherwise
‘‘moribund’’ human embryos (Lerou
et al., 2008), may have been ingenious re-
sponses to political pressures, but these
approaches basically ignore these central
facts about ART. If these new ARTs are
acceptable ethically as well as clinically,
then banning hESC derivation seems eth-
ically inconsistent. Perhaps it would be
more honest to think through, and even
to question, the biological basis of the
belief in the early embryo’s status, which
rests on the view that human identity is
fundamentally genetic (Johnson, 2001).
In the age of epigenetics, this view is
becoming increasingly difficult to defend
both scientifically and ethically.
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